JERUSALEM, July 17 (Reuters) – Israel’s CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Read more here.
JERUSALEM, July 17 (Reuters) – Israel’s CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Read more here.
![[ThetaRay in PR Newswire] ThetaRay Continues Global Expansion With Mexico Office Launch](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
